ReviewPharmacology & therapeutics2026

Irisin upregulation as a contributory mechanism for the therapeutic benefits of SGLT-2 inhibitors.

Natalia Motzko Noto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.